Replimune Group, Inc.REPLNASDAQ
Loading
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Gross Profit | -4 | -5 | 0 |
| Operating Income | -83 | -121 | -177 |
| Net Income | -81 | -118 | -174 |
| EBITDA | -76 | -114 | -172 |
| EPS Diluted | -1.75 | -2.26 | -2.99 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Cash & Equivalents | 183 | 106 | 147 |
| Total Current Assets | 484 | 404 | 593 |
| Total Assets | 543 | 461 | 647 |
| Total Current Liabilities | 15 | 21 | 34 |
| Total Liabilities | 44 | 50 | 91 |
| Total Equity | 499 | 411 | 555 |
| Total Debt | 33 | 33 | 61 |
| Net Debt | -149 | -73 | -86 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Operating Cash Flow | -61 | -82 | -128 |
| Capital Expenditure | -2 | -2 | -2 |
| Free Cash Flow | -64 | -85 | -130 |
| Stock-Based Comp | 12 | 24 | 28 |
| Net Change in Cash | 123 | -77 | 41 |